Development and evaluation of a novel chromium III-based compound for potential inhibition of emerging SARS-CoV-2 variants
Description
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused 403 million cases of coronavirus disease (COVID-19) and resulted in more than 5.7 million deaths worldwide. Extensive research has identified several potential drug treatments